MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 128 filers reported holding MYOKARDIA INC in Q3 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $447,000 | +24.2% | 3,282 | -11.8% | 0.23% | +37.6% |
Q2 2020 | $360,000 | +42.9% | 3,721 | -30.9% | 0.17% | +63.5% |
Q1 2020 | $252,000 | -44.0% | 5,383 | -12.8% | 0.10% | +40.5% |
Q4 2019 | $450,000 | +57.3% | 6,174 | +12.5% | 0.07% | +27.6% |
Q3 2019 | $286,000 | -1.4% | 5,487 | -5.2% | 0.06% | -4.9% |
Q2 2019 | $290,000 | +14.6% | 5,791 | +19.2% | 0.06% | -88.7% |
Q1 2019 | $253,000 | -7.3% | 4,859 | -13.1% | 0.54% | +1044.7% |
Q4 2018 | $273,000 | -56.7% | 5,594 | -42.1% | 0.05% | -27.7% |
Q3 2018 | $630,000 | -23.5% | 9,666 | -41.7% | 0.06% | -91.1% |
Q2 2018 | $823,000 | -14.0% | 16,580 | -15.4% | 0.73% | -12.3% |
Q1 2018 | $957,000 | +140.5% | 19,602 | +107.5% | 0.83% | +66.3% |
Q4 2017 | $398,000 | -16.7% | 9,447 | -15.4% | 0.50% | +679.7% |
Q3 2017 | $478,000 | +70.7% | 11,162 | -47.9% | 0.06% | +52.4% |
Q2 2017 | $280,000 | +1.8% | 21,407 | +2.5% | 0.04% | -14.3% |
Q1 2017 | $275,000 | +12.2% | 20,886 | +10.6% | 0.05% | -32.9% |
Q4 2016 | $245,000 | – | 18,884 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
Grace Capital | 23,400 | $3,190,000 | 2.47% |